Skip to main
SINT

SINT Stock Forecast & Price Target

SINT Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SINTX Technologies is a promising biomaterials and medical device company with strong early revenue and growth in continuing operations, positioned for potential partnerships and licensing opportunities due to its unique silicon nitride material. While there are challenges including slow surgeon adoption and competition, the recent FDA clearance for their foot and ankle surgery system and partnership with Evonik are positive indicators for future success. However, risks such as low cash position and regulatory hurdles must be considered for a full assessment of the investment opportunity.

Bears say

SINTX Technologies is an advanced ceramics company with a negative outlook due to concerns about slow adoption of their silicon nitride implants, execution risk in scaling operations, dependence on partnerships for expansion, and potential competitive pressure. The company's financials, such as their Q4 2025 results, did not meet expectations and there are risks related to regulatory oversight, patent enforcement, and competition from larger orthopedic manufacturers. However, there is potential for high rewards if the company can successfully commercialize their innovative biomaterial platform, which has shown promising biological and mechanical properties, and expand into new medical applications with the use of advanced manufacturing techniques.

SINT has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SINTX Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SINTX Technologies Inc (SINT) Forecast

Analysts have given SINT a Strong Buy based on their latest research and market trends.

According to 3 analysts, SINT has a Strong Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SINTX Technologies Inc (SINT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.